| Entry |
|
|---|
| Name |
Sucralfate (USP/INN);
Sucralfate hydrate (JP18);
Carafate (TN) |
|---|
| Product |
|
|---|
| Generic |
SUCRALFATE (A-S Medication Solutions), SUCRALFATE (A-S Medication Solutions), SUCRALFATE (A-S Medication Solutions), SUCRALFATE (ATLANTIC BIOLOGICALS CORP.), SUCRALFATE (Advanced Rx Pharmacy of Tennessee), SUCRALFATE (Advanced Rx Pharmacy of Tennessee), SUCRALFATE (Advanced Rx Pharmacy of Tennessee), SUCRALFATE (Advanced Rx Pharmacy of Tennessee), SUCRALFATE (American Health Packaging), SUCRALFATE (American Health Packaging), SUCRALFATE (Amneal Pharmaceuticals LLC), SUCRALFATE (Amneal Pharmaceuticals NY LLC), SUCRALFATE (Amneal Pharmaceuticals NY LLC), SUCRALFATE (Aphena Pharma Solutions - Tennessee), SUCRALFATE (Aphena Pharma Solutions - Tennessee), SUCRALFATE (AvKARE), SUCRALFATE (AvKARE), SUCRALFATE (AvPAK), SUCRALFATE (AvPAK), SUCRALFATE (Bryant Ranch Prepack), SUCRALFATE (Bryant Ranch Prepack), SUCRALFATE (Bryant Ranch Prepack), SUCRALFATE (Bryant Ranch Prepack), SUCRALFATE (Bryant Ranch Prepack), SUCRALFATE (Cardinal Health 107), SUCRALFATE (Chartwell RX), SUCRALFATE (DIRECT RX), SUCRALFATE (Direct_Rx), SUCRALFATE (Greenstone LLC), SUCRALFATE (Major Pharmaceuticals), SUCRALFATE (McKesson Corporation dba SKY Packaging), SUCRALFATE (McKesson Corporation dba SKY Packaging), SUCRALFATE (Mylan Institutional), SUCRALFATE (Mylan Pharmaceuticals), SUCRALFATE (NCS HealthCare of KY), SUCRALFATE (Northwind Pharmaceuticals), SUCRALFATE (Northwind Pharmaceuticals), SUCRALFATE (Nostrum Laboratories), SUCRALFATE (NuCare Pharmaceuticals), SUCRALFATE (PAI Holdings), SUCRALFATE (Pacific Pharma), SUCRALFATE (Par Pharmaceutical), SUCRALFATE (Precision Dose), SUCRALFATE (Preferred Pharmaceuticals), SUCRALFATE (Preferred Pharmaceuticals), SUCRALFATE (Proficient Rx LP), SUCRALFATE (REMEDYREPACK), SUCRALFATE (REMEDYREPACK), SUCRALFATE (REMEDYREPACK), SUCRALFATE (REMEDYREPACK), SUCRALFATE (RPK Pharmaceuticals), SUCRALFATE (Redpharm drug), SUCRALFATE (Teva Pharmaceuticals USA), SUCRALFATE (Viona Pharmaceuticals), SUCRALFATE (VistaPharm), SUCRALFATE (Zydus Lifesciences Limited) |
|---|
| Formula |
C12H14O11R8. xAlH3O3. yH2O
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG02008 Gastric mucosal protectant
|
|---|
| Remark |
| Therapeutic category: | 2329 |
| Product (DG00025): | D00446<JP/US> |
|
|---|
| Efficacy |
Anti-ulcerative, Antipepcin |
|---|
| Disease |
|
|---|
| Comment |
R: SO3Al(OH)2
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BX02 Sucralfate
D00446 Sucralfate (USP/INN) <JP/US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Protectants
Sucralfate
D00446 Sucralfate (USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
232 Peptic ulcer agents
2329 Others
D00446 Sucralfate (USP/INN); Sucralfate hydrate (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Agents for digestive organs
10 Antacids
D00446 Sucralfate (USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Sucralfate
D00446 Sucralfate (USP/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG02008 Gastric mucosal protectant
DG00025 Sucralfate
D00446 Sucralfate
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00446 Sucralfate hydrate
Drug groups [BR:br08330]
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG02008 Gastric mucosal protectant
DG00025 Sucralfate
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 36
1 C1z C 21.3189 -14.4796
2 C1y C 21.7452 -15.7816
3 O2a O 19.9999 -15.4079
4 O2x O 22.4866 -13.6390
5 C1b C 20.3381 -13.4814
6 C1y C 23.1638 -15.7816
7 O2a O 20.9221 -16.9200
8 C1y C 18.7914 -16.1085
9 C1y C 23.6133 -14.4563
10 O2a O 23.9753 -16.9257
11 R R 21.4941 -18.1926
12 C1y C 18.7914 -17.5096
13 O2x O 17.5653 -15.4079
14 C1b C 24.9503 -14.0361
15 R R 23.3915 -18.1985
16 C1y C 17.5653 -18.2102
17 O2a O 19.9940 -18.2102
18 C1y C 16.3628 -16.1142
19 C1y C 16.3628 -17.5096
20 O2a O 17.5596 -19.6054
21 R R 19.9882 -19.6054
22 C1b C 15.1484 -15.4079
23 O2a O 15.1484 -18.2102
24 R R 16.3452 -20.3003
25 O2a O 25.9815 -14.9828
26 R R 27.3074 -14.5660
27 O2a O 19.0062 -13.8264
28 R R 18.0580 -12.8621
29 O2a O 13.9161 -16.1145
30 R R 12.7100 -15.4133
31 R R 13.9105 -17.4949
32 Z Al 28.5340 -18.6793
33 O1a O 28.5269 -17.2825
34 O1a O 27.3279 -19.3838
35 O1a O 29.9571 -19.3716
36 O0 O 35.1075 -18.3830
BOND 35
1 1 4 1
2 1 5 1
3 2 6 1
4 2 7 1 #Down
5 8 3 1 #Down
6 4 9 1
7 6 10 1 #Up
8 7 11 1
9 8 12 1
10 8 13 1
11 9 14 1 #Down
12 10 15 1
13 12 16 1
14 12 17 1 #Down
15 13 18 1
16 16 19 1
17 16 20 1 #Up
18 17 21 1
19 18 22 1 #Up
20 19 23 1 #Down
21 20 24 1
22 6 9 1
23 18 19 1
24 1 2 1
25 1 3 1 #Down
26 14 25 1
27 25 26 1
28 5 27 1
29 27 28 1
30 22 29 1
31 29 30 1
32 23 31 1
33 32 33 1
34 32 34 1
35 32 35 1
BRACKET 1 26.1800 -20.3700 26.1800 -16.4500
1 31.0800 -16.4500 31.0800 -20.3700
1 x
ORIGINAL 1 32 33 34 35
REPEAT 1
2 33.4600 -19.3200 33.4600 -17.4300
2 35.5600 -17.4300 35.5600 -19.3200
2 y
ORIGINAL 2 36
REPEAT 2
|
|---|
|
